BlackRock Institutional Trust’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

BlackRock Institutional Trust’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,968,630	Closed	-$84.2M	–	3991
2014 Q4	$84.2M	Buy	4,968,630 +391,135	+9%	+$5.5M	0.01%	977
2014 Q3	$54.6M	Sell	4,577,495 -100,935	-2%	-$689K	0.01%	1193
2014 Q2	$26.4M	Sell	4,678,430 -83,511	-2%	-$385K	﹤0.01%	1766
2014 Q1	$17.5M	Buy	4,761,941 +123,907	+3%	+$472K	﹤0.01%	2058
2013 Q4	$15.6M	Buy	4,638,034 +138,322	+3%	+$571K	﹤0.01%	2128
2013 Q3	$19M	Sell	4,499,712 -100,290	-2%	-$475K	﹤0.01%	1892
2013 Q2	$21.2M	Buy	+4,600,002	New	+$15.8M	﹤0.01%	1766

BlackRock Institutional Trust's AVNR Position: Q1 2015 in Review

BlackRock Institutional Trust sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 4,968,630 shares — an estimated $84.2M sold.

BlackRock Institutional Trust first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $84.2M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

BlackRock Institutional Trust reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
BlackRock Institutional Trust sold 4,968,630 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $84.2M.
BlackRock Institutional Trust first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
BlackRock Institutional Trust's AVANIR PHARMACEUTICALS, INC CL A position peaked at $84.2M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on BlackRock Institutional Trust's 13F filing for Q1 2015, filed 13 May 2015.